Abstract
Oxfenicine (S-4-hydroxyphenyl glycine) has been shown to protect the rat and dog heart from experimentally induced myocardial ischaemia probably as a result of its ability to divert myocardial metabolism from fatty acid to carbohydrate utilization with a consequent reduction in oxygen consumption. When various dose levels of oxfenicine were administered to dogs for periods of up to 1 year and rats for periods of up to 2 years, dose-related increases in cardiac weight were observed. No increases in cardiac weight were observed in the rat after only 3 months of treatment but increases were observed in the dogs after a similar treatment period. Macroscopic, light, histochemical and electron microscopic examination of the myocardium revealed that the increase in heart weight was due to uniform myocardial fibre hypertrophy involving all cardiac chambers. Individual muscle fibres were increased in size but there was no clear disproportion of mitochondria and myofibrils. Although intracellular lipid was increased, vacuolated lysosomal structures were only occasionally observed. No histochemical differences in lysosomal enzyme activity were observed between the treated and the control rats. The structural changes were fully compatible with myocardial hypertrophy due to the decreased energy forming capacity of heart muscle resulting from inhibition of fatty acid oxidation by oxfenicine.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Adams MG, Barer R, Joseph S, Ominiabohs F (1981) Fat accumulation in the rat heart during fasting. J Pathol 135: 111–126
Atkinson L, Bergman G, Jackson N, Jewitt DE, Metcalfe JM (1979) Potential protective value of enhanced myocardial carbohydrate utilisation with reduced free fatty acid uptake after UK-25,842 in patients with coronary artery disease. Br J Pharmacol 66: 444
Burges RA, Gardiner DG, Higgins AJ (1981) Protection of the ischaemic dog heart by oxfenicine. Life Sci 29: 1847–1853
Chayen J, Bitensky L, Butcher R (1973) Practical histochemistry, part VI. Enzyme histochemistry. Wiley, London, pp 99–213
Ferrans VJ (1981) Overview of morphological reactions of the heart to toxic injury. In: Balaz T (ed) Cardiac toxicity, vol 3, chap 4. CRC Press, Boca Raton, pp 83–109
Greaves P, Martin J, Masson MT (1982) Spontaneous rat malignant tumors of fibrohistocytic origin: An ultrastructural study. Vet Pathol 19: 497–505
Higgins AJ, Morville M, Burges RA, Gardiner DG, Page MG, Blackburn KS (1980) Oxfenicine diverts rat muscle metabolism from fatty acid to carbohydrate oxidation and protects the ischaemic rat heart. Life Sci 27: 963–970
Laks MM, Morady F, Swan HJC (1973) Myocardial hypertrophy produced by chronic infusion of subhypertensive doses of norepinephrine in the dog. Chest 64: 75–78
Rossi MA, Zucoloto S (1982) Ultrastructural changes in nutritional cardiopathy of protein-calorie malnourished rats. Br J Exp Pathol 63: 242–253
Skelton CL, Sonnenblick EH (1974) Heterogeneity of contractile function in cardiac hypertrophy. Circ Res [Suppl 34–35] 2: 83–96
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1984 Springer-Verlag
About this paper
Cite this paper
Greaves, P., Martin, J., Michel, M.C., Mompon, P. (1984). Cardiac Hypertrophy in the Dog and Rat Induced by Oxfenicine, an Agent Which Modifies Muscle Metabolism. In: Chambers, P.L., Preziosi, P., Chambers, C.M. (eds) Disease, Metabolism and Reproduction in the Toxic Response to Drugs and Other Chemicals. Archives of Toxicology, vol 7. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-69132-4_103
Download citation
DOI: https://doi.org/10.1007/978-3-642-69132-4_103
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-12452-8
Online ISBN: 978-3-642-69132-4
eBook Packages: Springer Book Archive